Search results
Roche's New Immunotherapy Fails To Show Benefit Over Merck's Blockbuster Keytruda In Lung Cancer...
Benzinga via Yahoo Singapore Finance· 1 day agoOn Thursday, Roche Holdings AG (OTC:RHHBY) said that the Phase 2/3 SKYSCRAPER-06 study of...
Merck (NYSE:MRK) Seems To Use Debt Quite Sensibly
Simply Wall St. via Yahoo Singapore Finance· 3 days agoIt's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved when a business collapses. As with...
mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment
Benzinga via Yahoo Singapore Finance· 4 days agoThe beauty of mRNA technology is that it opens the door to a more personalized and effective...
AstraZeneca (AZN) Imfinzi Combo Gets CHMP Nod for Expanded Use
Zacks via Yahoo Singapore Finance· 4 days agoThe CHMP recommends approval of AstraZeneca's (AZN) Imfinzi plus Lynparza for treating primary...
What's Going On With Merck Stock On Monday?
Benzinga via Yahoo Singapore Finance· 5 days agoOn Monday, Merck & Co Inc (NYSE:MRK) announced the notice of the mutual exercise of an option to convert the companies’ ongoing
The Top Country With Most Scientists per Capita in the World
Insider Monkey via Yahoo Singapore Finance· 7 days agoWe recently compiled a list of the 10 Countries With the Most Scientists per Capita in the World and...